Soligenix Extends Patent Protection for Its Filovirus Vaccine Platform To UK And South Africa
Soligenix Extends Patent Protection for Its Filovirus Vaccine Platform To UK And South Africa
Soligenix 將其 Filovirus 疫苗平台的專利保護範圍擴大到英國和南非
- Includes thermostabilized Ebola vaccines MarVax and SuVax
- Includes nanoemulsion adjuvant compatible with lyophilization
- 包括熱穩定埃博拉疫苗 MarvaX 和 SuvaX
- 包括與凍幹兼容的納米乳液輔助劑
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。